Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Activated charcoal to reduce fecal ceftriaxone and protect gut microbiota
TCTR20190917003Phase 0Not yet recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of ceftriaxone and activated charcoal in Infection (2 arms), sponsored by Faculty of Medicine, Chulalongkorn University. Primary endpoint: Fecal ceftriaxone concentration. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
ceftriaxoneactivated charcoal
03
Conditions
Infection
Beyond the preview
Go deeper on TCTR20190917003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190917003.